Dynamically linking influenza virus infection kinetics, lung injury, inflammation, and disease severity

  1. Margaret A Myers
  2. Amanda P Smith
  3. Lindey C Lane
  4. David J Moquin
  5. Rosemary Aogo
  6. Stacie Woolard
  7. Paul Thomas
  8. Peter Vogel
  9. Amber M Smith  Is a corresponding author
  1. University of Tennessee Health Science Center, United States
  2. University of Tennessee Health Science C, United States
  3. Washington University School of Medicine, United States
  4. St Jude Children's Research Hospital, United States

Abstract

Influenza viruses cause a significant amount of morbidity and mortality. Understanding host immune control efficacy and how different factors influence lung injury and disease severity are critical. We established and validated dynamical connections between viral loads, infected cells, CD8+ T cells, lung injury, inflammation, and disease severity using an integrative mathematical model-experiment exchange. Our results showed that the dynamics of inflammation and virus-inflicted lung injury are distinct and nonlinearly related to disease severity, and that these two pathologic measurements can be independently predicted using the model-derived infected cell dynamics. Our findings further indicated that the relative CD8+ T cell dynamics paralleled the percent of the lung that had resolved with the rate of CD8+ T cell-mediated clearance rapidly accelerating by over 48,000 times in 2 days. This complimented our analyses showing a negative correlation between the efficacy of innate and adaptive immune-mediated infected cell clearance, and that infection duration was driven by CD8+ T cell magnitude rather than efficacy and could be significantly prolonged if the ratio of CD8+ T cells to infected cells was sufficiently low. These links between important pathogen kinetics and host pathology enhance our ability to forecast disease progression, potential complications, and therapeutic efficacy.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided.

Article and author information

Author details

  1. Margaret A Myers

    Pediatrics, University of Tennessee Health Science Center, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Amanda P Smith

    Pediatrics, University of Tennessee Health Science C, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Lindey C Lane

    Pediatrics, University of Tennessee Health Science C, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. David J Moquin

    Anesthesiology, Washington University School of Medicine, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Rosemary Aogo

    Pediatrics, University of Tennessee Health Science Center, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Stacie Woolard

    Flow Cytometry Core, St Jude Children's Research Hospital, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Paul Thomas

    Flow Cytometry Core, St Jude Children's Research Hospital, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Peter Vogel

    Veterinary Pathology Core, St Jude Children's Research Hospital, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Amber M Smith

    Pediatrics, University of Tennessee Health Science Center, Memphis, United States
    For correspondence
    amber.smith@uthsc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7092-6904

Funding

National Institute of Allergy and Infectious Diseases (AI139088)

  • Margaret A Myers
  • Amanda P Smith
  • Lindey C Lane
  • Rosemary Aogo

National Institute of Allergy and Infectious Diseases (AI125324)

  • Margaret A Myers
  • Amanda P Smith
  • Lindey C Lane
  • David J Moquin
  • Amber M Smith

National Institute of Allergy and Infectious Diseases (AI100946)

  • Amber M Smith

American Lebanese Syrian Associated Charities (Internal Funding)

  • Margaret A Myers
  • Amanda P Smith
  • Lindey C Lane
  • David J Moquin
  • Stacie Woolard
  • Paul Thomas
  • Peter Vogel
  • Amber M Smith

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Joshua T Schiffer, Fred Hutchinson Cancer Research Center, United States

Ethics

Animal experimentation: All experimental procedures were performed under protocols O2A-020 or 17-096 approved by the Animal Care and Use Committees at St. Jude Children's Research Hospital (SJCRH) or the University of Tennessee Health Science Center (UTHSC), respectively, under relevant institutional and American Veterinary Medical Association (AVMA) guidelines. All experimental procedures were performed in a biosafety level 2 facility that is accredited by the American Association for Laboratory Animal Science (AALAS).

Version history

  1. Preprint posted: February 19, 2019 (view preprint)
  2. Received: March 28, 2021
  3. Accepted: July 14, 2021
  4. Accepted Manuscript published: July 20, 2021 (version 1)
  5. Version of Record published: August 17, 2021 (version 2)

Copyright

© 2021, Myers et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,777
    views
  • 397
    downloads
  • 35
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Margaret A Myers
  2. Amanda P Smith
  3. Lindey C Lane
  4. David J Moquin
  5. Rosemary Aogo
  6. Stacie Woolard
  7. Paul Thomas
  8. Peter Vogel
  9. Amber M Smith
(2021)
Dynamically linking influenza virus infection kinetics, lung injury, inflammation, and disease severity
eLife 10:e68864.
https://doi.org/10.7554/eLife.68864

Share this article

https://doi.org/10.7554/eLife.68864

Further reading

    1. Computational and Systems Biology
    2. Developmental Biology
    Arya Y Nakhe, Prasanna K Dadi ... David A Jacobson
    Research Article

    The gain-of-function mutation in the TALK-1 K+ channel (p.L114P) is associated with maturity-onset diabetes of the young (MODY). TALK-1 is a key regulator of β-cell electrical activity and glucose-stimulated insulin secretion. The KCNK16 gene encoding TALK-1 is the most abundant and β-cell-restricted K+ channel transcript. To investigate the impact of KCNK16 L114P on glucose homeostasis and confirm its association with MODY, a mouse model containing the Kcnk16 L114P mutation was generated. Heterozygous and homozygous Kcnk16 L114P mice exhibit increased neonatal lethality in the C57BL/6J and the CD-1 (ICR) genetic background, respectively. Lethality is likely a result of severe hyperglycemia observed in the homozygous Kcnk16 L114P neonates due to lack of glucose-stimulated insulin secretion and can be reduced with insulin treatment. Kcnk16 L114P increased whole-cell β-cell K+ currents resulting in blunted glucose-stimulated Ca2+ entry and loss of glucose-induced Ca2+ oscillations. Thus, adult Kcnk16 L114P mice have reduced glucose-stimulated insulin secretion and plasma insulin levels, which significantly impairs glucose homeostasis. Taken together, this study shows that the MODY-associated Kcnk16 L114P mutation disrupts glucose homeostasis in adult mice resembling a MODY phenotype and causes neonatal lethality by inhibiting islet insulin secretion during development. These data suggest that TALK-1 is an islet-restricted target for the treatment for diabetes.

    1. Computational and Systems Biology
    David Geller-McGrath, Kishori M Konwar ... Jason E McDermott
    Tools and Resources

    The reconstruction of complete microbial metabolic pathways using ‘omics data from environmental samples remains challenging. Computational pipelines for pathway reconstruction that utilize machine learning methods to predict the presence or absence of KEGG modules in incomplete genomes are lacking. Here, we present MetaPathPredict, a software tool that incorporates machine learning models to predict the presence of complete KEGG modules within bacterial genomic datasets. Using gene annotation data and information from the KEGG module database, MetaPathPredict employs deep learning models to predict the presence of KEGG modules in a genome. MetaPathPredict can be used as a command line tool or as a Python module, and both options are designed to be run locally or on a compute cluster. Benchmarks show that MetaPathPredict makes robust predictions of KEGG module presence within highly incomplete genomes.